Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0280
+0.0002 (0.72%)
At close: Sep 12, 2025
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $1.19 million as of September 12, 2025. Its market cap has decreased by -66.77% in one year.
Market Cap
1.19M
Enterprise Value
-6.14M
Revenue
5.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from 38.73M to 1.19M, a decrease of -96.94%. That is a compound annual growth rate of -51.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 1.18M | -70.14% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
| Dec 2, 2020 | 38.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 739.37M |
| Tian'an Technology Group | 675.94M |
| Glass House Brands | 608.81M |
| CytoDyn | 424.27M |
| Northwest Biotherapeutics | 378.39M |
| American Oncology Network | 353.52M |